Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

Abstract This study aimed to develop the feasible and effective universal screening strategy of the notable SARS-CoV-2 variants by Sanger Sequencing Strategy and then practically applied it for mass screening in Hiroshima, Japan. A total of 734 samples from COVID-19 confirmed cases in Hiroshima were...

Full description

Bibliographic Details
Main Authors: Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Bunthen E, Serge Ouoba, Md Razeen Ashraf Hussain, Tomoyuki Akita, Aya Sugiyama, Takemasa Sakaguchi, Hidetoshi Tahara, Hiroki Ohge, Hideki Ohdan, Tatsuhiko Kubo, Nobuhisa Ishikawa, Toshiro Takafuta, Yoshiki Fujii, Michi Mimori, Fumie Okada, Eisaku Kishita, Kunie Ariyoshi, Masao Kuwabara, Junko Tanaka
Format: Article
Language:English
Published: Nature Portfolio 2022-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-04952-2

Internet

https://doi.org/10.1038/s41598-022-04952-2

Similar Items